The association of drugs with lipoproteins can affect their pharmacological and toxicological activities. Here, the authors discuss the mechanisms of drug uptake into lipoproteins and the impact of such interactions, ways to improve the therapeutic profile of hydrophobic drugs, and the ensuing opportunities for drug discovery and development programmes.
- Kishor M. Wasan
- Dion R. Brocks
- Sheila J. Thornton
